Vericel Stock 10%. Here's What the Insider Sale Signals
A 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
Extra expenses call for smart tweaks. This intro covers simple ways to adjust your budget to accommodate additional costs.
12,871 articlesA 10% move in Vericel stock drew attention after a COO sold shares worth $402,000. This article breaks down what the ...
Inflation remains a headwind for cash savers. This report outlines a three-ETF approach designed for someone who’s ne...
A major director sale in a blockchain-focused company can raise questions about risk and opportunity. This deep dive ...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
If you’re looking for a steadier way to grow wealth over the long term, bank stock can be part of the answer. This gu...
A DXP Enterprises director sold nearly 7,000 shares in a single transaction. This article breaks down the details, ex...
A CFO selling a substantial stake can spark questions about a company’s short-term risk and long-term strategy. This ...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...
Choosing the right AI exposure can feel tricky. This article breaks down which better artificial intelligence path fi...
Palantir's CEO used a televised interview to question AI pricing models, highlighting data ownership and sovereignty ...
A growing number of seniors report t-bills more than salary as short-term yields rise, complicating the Social Securi...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...